Methods and compositions for treating complement-associated disorders

摘要: The present disclosure relates to, inter alia, compositions containing an inhibitor of human complement and use the in methods for treating or preventing complement-associated disorders. In some embodiments, is chronically administered to patients. a patient amount with frequency maintain systemic inhibition prevent breakthrough. contain antibody, antigen-binding fragment thereof, that binds component C5 protein such as C5a C5b.